Siegfried, a global CDMO, has announced a major expansion of its ophthalmic drug manufacturing site in El Masnou, near Barcelona, Spain. The investment responds to growing customer demand for sterile eye drops and enhances the company’s footprint in contract manufacturing
Siegfried, a global contract development and manufacturing organization (CDMO) headquartered in Zofingen, Switzerland, has signed agreements with Curia Global for the acquisition of an early-phase CDMO site in Grafton, WI. The transaction is expected to close by July 1, 2024.
Siegfried has announced the acquisition of a new site that specialises in early-phase development and manufacturing services. The site, staffed by an experienced team of over 80 employees, is expected to enhance Siegfried’s customer offering for Drug Substances in terms of
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
